ImmunityBio, Inc. IBRX
At closeNov 13, 2026, 4:47 AM EST
Pre-market · Nov 13, 4:47 AM ET
- YTD
- +206.57%
- 1 year
- +194.66%
Discussion (3508)
Sign in to join the discussion
Saudi's can do what ever they want to do.
They act on the facts with no bias or obligation to big pharma or the MSM get it ..............
Fuck the FDA and EU who needs them 8 billion people so who cares about less than 700 million
Most of the posts on here remind me of the dumb kids I grew up with.
Ok morons this is what is going to happen.
Saudi's gave full bladder cancer approval. They gave non-Small cell lung cancer approval. As the Saudi's start using Anktiva and see the incredible results they will start using it off Label for multiple cancers. The results will be incredible and soon the world will know and everyone will know Anktiva is the future for cancer therapy.
Dr.PSS is a genius. The US is 4-5% of the world's population so why worry about the FDA?.?.?. Get it? Do you understand.?.? He is like Trump playing chess with a world of morons that play checkers....
Oops bad math will sell 40,000 at $50 pull 2 million out which is my cost basis and let the rest run
420,000 shares won't sell a single share until $50 at $50 will pull 1/2 of my cost basis 40,000 let the rest ride to triple digits
Rocket to the close and start the long term climb to $100 plus POS Moderna MRNA hit $384
Mike Scott long term to $100 plus this is the future of all cancer therapy and treating infections tonto elevate NK kill cells
Baby $IBRX bounce to $21
I Have Many
Get off the board don't waste my time it took to open a juvenile inane post that a
Teenager would post . GO AWAY AND GROW UP....
